novo oral glp-1 Nordisk's Wegovy Pill Becomes First FDA-Approved Drug for Weight Loss CNBC (April 7): Novo Nordisk's

Lack of sleep, stress and aging factor bums you out and lets be real, DIY methods are way too time consuming and less effective as well

10.3389/fphar.2023.975830 Front

Who Should Prioritize Fatigue Assessment Before Starting Therapy Patients with pre-existing conditionsthyroid disease, chronic anemia, autoimmune conditions, or a history of nutrient malabsorptionshould undergo baseline micronutrient and metabolic screening before initiating GLP-1 therapy

Early benefits may have been symptomatic, not disease-modifying In the initial trials, patients on exenatide ended with better MDS-UPDRS-3 motor scores than at baseline , a surprising finding for a disease-modifying drug

Pharmaceutical Biology 53:16321638

Interest also includes how this peptide may interact with exercise related pathways and adaptive physiology